SHERWIN STEPHEN A — SEC Form 4 filings
SEC reporting owner CIK 1079462. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-05-21 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 4 filings — 87,591 shares, $12,399,598 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 25,000 shares @ $133.46 ($3,336,555) in NEUROCRINE BIOSCIENCES INC, filed 2024-05-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Director | 11 | — | 8 legs · 78,831 sh · $11,085,456 | 20 |
| BIOGEN INC. (BIIB) | Director | 4 | — | 1 leg · 8,760 sh · $1,314,142 | 3 |
Form 4 filings — SHERWIN STEPHEN A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Gift (G): 1,000 @ $0 | EDGAR |
| 2026-06-11 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,505 @ $0 | EDGAR |
| 2026-06-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 15,000 @ $53.64 · Option exercise (M): 10,000 @ $79.79 · Sale (S): 7,883 @ $163.81 · Sale (S): 2,549 @ $164.44 · Sale (S): 6,896 @ $165.79 · Sale (S): 5,829 @ $166.56 · +3 more | EDGAR |
| 2026-05-29 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,567 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Gift (G): 1,000 @ $0 | EDGAR |
| 2025-06-18 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 2,370 @ $0 | EDGAR |
| 2025-05-22 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,869 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 2,869 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | BIOGEN INC. (BIIB) | Sale (S): 8,760 @ $150.02 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 13,831 @ $116.69 | EDGAR |
| 2024-11-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Gift (G): 2,000 @ $0 | EDGAR |
| 2024-06-25 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,340 @ $0 | EDGAR |
| 2024-05-30 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 25,000 @ $42.76 · Sale (S): 25,000 @ $133.46 · Option exercise (M): 15,000 @ $47.89 · Sale (S): 15,000 @ $133.47 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,869 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,199 @ $0 · Option exercise (M): 4,199 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1079462 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →